October 02, 2014 4:15 AM ET

Pharmaceuticals

Company Overview of Xenova Group Limited

Company Overview

Xenova Group Limited, a biopharmaceutical company, develops drugs for the treatment of cancer and addiction, with a secondary focus on immunology. It develops three cancer programs that include TransMIDTM, which is in Phase III trials for the treatment of high-grade glioma; and DNA targeting agents and XR303 that are in Phase I for cancer indications. The company also develops two therapeutic vaccines for cocaine and nicotine addiction, which are in Phase II and Phase I trials respectively. The company was founded in 1987 and is headquartered in Slough, United Kingdom. Xenova Group Limited operates as a subsidiary of Celtic Pharma Development UK Plc. As of April 15, 2014, Xenova Group Limite...

957 Buckingham Avenue

Slough,  SL1 4NL

United Kingdom

Founded in 1987

75 Employees

Phone:

44 17 5370 6600

Fax:

44 17 5370 6607

Key Executives for Xenova Group Limited

Director of Manufacturing and Process Development and Member of Senior Management Team
Age: 69
Director of Regulatory Affairs and Development Operations and Executive Director
Age: 51
Director of Intellectual Property
Age: 66
Medical Director of North America
Age: 63
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Celentyx Ltd. Europe
Bioprogress Technology Ltd. Europe
The Native Antigen Company Ltd. Europe
Life Sciences Research Ltd. Europe
Ipsen Developments Limited Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Xenova Group Limited, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.